Market Cap Chart

Historical Market Cap Data

View and export this data back to 2019. Start Trial.
Date Value
October 02, 2026 170.27M
October 01, 2026 179.34M
September 30, 2026 185.38M
September 29, 2026 183.87M
September 28, 2026 186.90M
September 25, 2026 185.64M
September 24, 2026 187.90M
September 23, 2026 181.35M
September 22, 2026 187.90M
September 21, 2026 182.87M
September 18, 2026 183.87M
September 17, 2026 185.38M
September 16, 2026 183.37M
September 15, 2026 184.88M
September 14, 2026 195.96M
September 11, 2026 194.45M
September 10, 2026 192.94M
September 09, 2026 201.76M
September 08, 2026 210.57M
September 04, 2026 216.62M
September 03, 2026 213.60M
September 02, 2026 216.62M
September 01, 2026 206.54M
August 31, 2026 208.05M
August 28, 2026 211.58M
Date Value
August 27, 2026 218.13M
August 26, 2026 219.39M
August 25, 2026 221.15M
August 24, 2026 218.13M
August 21, 2026 220.14M
August 20, 2026 213.60M
August 19, 2026 208.56M
August 18, 2026 201.00M
August 17, 2026 201.50M
August 14, 2026 196.47M
August 13, 2026 200.50M
August 12, 2026 204.53M
August 11, 2026 207.55M
August 10, 2026 207.05M
August 07, 2026 210.07M
August 06, 2026 199.99M
August 05, 2026 199.99M
August 04, 2026 198.48M
August 03, 2026 194.96M
July 31, 2026 194.45M
July 30, 2026 202.01M
July 29, 2026 194.45M
July 28, 2026 198.48M
July 27, 2026 198.56M
July 24, 2026 194.54M

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
Autolus Therapeutics Plc 473.77M
Akari Therapeutics Plc 15.26M
Cellectis SA 144.00M
DBV Technologies SA 624.38M
Oxford Biomedica Plc 866.65M

Market Cap Related Metrics

PS Ratio 3.849
Price to Book Value 0.4625
Price 3.38
Earnings Yield -80.81%